We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Mazor Robotics Introduces Mazor X for Robotic Spine Surgery
Read MoreHide Full Article
Mazor Robotics Ltd. , an Israel-based developer of robotic technology and products, recently introduced Mazor X, a revolutionary platform for spine surgeries using highly automated robotic technologies.
The company is slated to commercially launch the FDA-cleared Mazor X by Oct 2016. Meanwhile, Mazor Robotics recently agreed to a commercial co-promotion and co-development deal with Medtronic (MDT - Free Report) , under which the latter has already added 15 Mazor X systems to its cart.
Mazor X is an assurance platform in the market of spinal surgeries that provides a unified solution to all the tribulations associated to spinal surgery. The uniqueness of the product is concealed in its functioning technique, as it utilizes multidisciplinary principles of analytical tools, multiple data-source, precision guidance, optical tracking, intra-operative verification and connectivity technologies to address the target market.
Mazor X collaborates three major processes, namely, Pre-operative analytics, Intra operative Guidance and Realtime 3D Verification to generate accurate results. Notably, the X-Align module of the Pre-operative analytics process creates a holistic alignment plan for patients by combining biomechanical logic and virtual surgical tools (computerized calculations).
Mazor Robotics has been keen on transforming spine surgery from freehand procedures to highly efficient robotic technologies for long. Notably, the Renaissance Guidance system of the company is a similar product that provides spinal surgical solutions using high-end technologies. As per a report by StarTribune, more than 16,000 successful spinal surgeries have been done worldwide with the Renaissance system.
We believe that the introduction of this new system will expand Mazor Robotics’ portfolio of robot-based spinal surgery products. In fact, the recently formed partnership with Medtronic is going to enhance Mazor Robotics’ market reach and propel growth over the long haul. Notably, the company has received 11 Renaissance system orders in the second quarter of 2016.
The Mazor X is likely to be a path breaker, as it is the result of all the attempts by the company over the past several years to proactively reach target customers in the market of robot-based spinal surgeries. We believe that this will drive the company’s top-line growth in the long haul.
Zacks Rank & Key Picks
Currently, Mazor Robotics has a Zacks Rank #4 (Sell).
Better-ranked stocks in the medical instrument sector include ABIOMED Inc. , Masimo Corporation (MASI - Free Report) and Medtronic plc. (MDT - Free Report) . Notably, ABIOMED and Masimo Corporation sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
Unique Zacks Analysis of Your Chosen Ticker
Pick one free report - opportunity may be withdrawn at any time
Image: Bigstock
Mazor Robotics Introduces Mazor X for Robotic Spine Surgery
Mazor Robotics Ltd. , an Israel-based developer of robotic technology and products, recently introduced Mazor X, a revolutionary platform for spine surgeries using highly automated robotic technologies.
The company is slated to commercially launch the FDA-cleared Mazor X by Oct 2016. Meanwhile, Mazor Robotics recently agreed to a commercial co-promotion and co-development deal with Medtronic (MDT - Free Report) , under which the latter has already added 15 Mazor X systems to its cart.
Mazor X is an assurance platform in the market of spinal surgeries that provides a unified solution to all the tribulations associated to spinal surgery. The uniqueness of the product is concealed in its functioning technique, as it utilizes multidisciplinary principles of analytical tools, multiple data-source, precision guidance, optical tracking, intra-operative verification and connectivity technologies to address the target market.
Mazor X collaborates three major processes, namely, Pre-operative analytics, Intra operative Guidance and Realtime 3D Verification to generate accurate results. Notably, the X-Align module of the Pre-operative analytics process creates a holistic alignment plan for patients by combining biomechanical logic and virtual surgical tools (computerized calculations).
MAZOR ROBOTICS Price and Consensus
MAZOR ROBOTICS Price and Consensus | MAZOR ROBOTICS Quote
Mazor Robotics has been keen on transforming spine surgery from freehand procedures to highly efficient robotic technologies for long. Notably, the Renaissance Guidance system of the company is a similar product that provides spinal surgical solutions using high-end technologies. As per a report by StarTribune, more than 16,000 successful spinal surgeries have been done worldwide with the Renaissance system.
We believe that the introduction of this new system will expand Mazor Robotics’ portfolio of robot-based spinal surgery products. In fact, the recently formed partnership with Medtronic is going to enhance Mazor Robotics’ market reach and propel growth over the long haul. Notably, the company has received 11 Renaissance system orders in the second quarter of 2016.
The Mazor X is likely to be a path breaker, as it is the result of all the attempts by the company over the past several years to proactively reach target customers in the market of robot-based spinal surgeries. We believe that this will drive the company’s top-line growth in the long haul.
Zacks Rank & Key Picks
Currently, Mazor Robotics has a Zacks Rank #4 (Sell).
Better-ranked stocks in the medical instrument sector include ABIOMED Inc. , Masimo Corporation (MASI - Free Report) and Medtronic plc. (MDT - Free Report) . Notably, ABIOMED and Masimo Corporation sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>